FibriArt-I Receives CDSCO Approval for AI-Based Wearable Device for Arrhythmia Screening and Monitoring

Ahmedabad, India – 17-Aug- 2026 — Topia MedTech announced that FibriArt’s AI-based wearable cardiac monitoring device FibriArt-I has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Licence Number MFG/MD/2026/000595.

The approval marks an important regulatory milestone for Topia MedTech and its FibriArt cardiac monitoring platform, strengthening the company's focus on connected and wearable technologies for cardiac health.

FibriArt-I: Wearable ECG Monitoring

FibriArt-I is designed to capture and record ECG data in a convenient, connected format. The device supports ECG recording and wireless data transfer through the FibriArt mobile application.

FibriArt-I is a plug-and-play, easy-to-use device designed for home healthcare, enabling seamless ECG recording without the need for parameter-specific setup. It supports remote monitoring and allows healthcare professionals to access and review patient data effortlessly. The device can also generate shareable PDF reports, simplifying communication and continuity of cardiac care from home to clinician.

By combining wearable ECG recording, wireless connectivity, and digital reporting, FibriArt-I is designed to support convenient cardiac rhythm monitoring.

Supporting Arrhythmia Screening and Monitoring

Arrhythmias can occur intermittently, making ECG recording an important part of cardiac rhythm assessment. FibriArt-I brings ECG recording and digital connectivity together in a wearable format, supporting the collection of cardiac rhythm information for review by qualified healthcare professionals.

The CDSCO approval represents a significant step in the continued development and expansion of the FibriArt portfolio in India.

Dr. Debanjan Parbat, General Manager of FibriArt, said:

“The CDSCO approval of FibriArt-I is an important milestone for Topia MedTech and FibriArt. It reflects our continued commitment to developing connected cardiac monitoring technologies that make ECG recording more convenient while providing structured cardiac information for healthcare professionals.”

About FibriArt

FibriArt, developed by Topia MedTech, is a cardiac monitoring platform focused on wearable ECG devices and connected cardiac health technologies. FibriArt-I is designed for ECG recording, wireless data transfer, and digital reporting to support cardiac rhythm monitoring workflows.

For more information, visit fibriart.com.

About Topia MedTech

Topia MedTech develops medical technologies across cardiac health and medical imaging, with a focus on AI-enabled, connected, and accessible healthcare solutions designed to support modern clinical workflows.

Interested in FibriArt-I?

Healthcare providers, distributors, and businesses can contact our team to learn more about FibriArt-I, product availability, purchasing, and distribution opportunities.